re: Ann: Important GSK initiatives to new inf... Definitely good news medium term. Do your own P/E calculation. With 174k shares outstanding and PBT of at least $100m pa until Relenza patents expire (2011-2014) with LANI coming through before then, BTA has to be worth at least $3-4 a share even with current management.
Ann: Important GSK initiatives to new influenza A, page-11
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)